Menquadfi vial 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FK8LH
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,559
Award facts
- Contract value 100% obligated
- $1,559.06 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $1,559.06 by the Defense Logistics Agency (DLA) for MENQUADFI VIAL 0.5ML. This firm fixed-price delivery order, awarded on April 22, 2025, with an ultimate completion date of April 23, 2025, represents a specific pharmaceutical product requisition under the company's existing contract vehicle. The award carries no set-aside designation, allowing DMS Pharmaceutical Group to compete directly for the order based on its established vendor qualifications and pricing terms.
This delivery order is issued under DMS Pharmaceutical Group's significant Indefinite Delivery Contract with the DLA valued at $499,999,999 and valid through November 2026, which enables the agency to procure a comprehensive range of pharmaceutical products supporting military health facilities worldwide. The SPE2DB program vehicle authorizes firm fixed-price delivery orders for branded and generic prescription drugs, biologics, and medical consumables across multiple product categories. DMS Pharmaceutical Group's role as a critical supplier in the federal pharmaceutical supply chain reflects the DLA's reliance on the company for consistent distribution of specialized medications and vaccines to Department of Defense healthcare sites.
Quick answers
Who was awarded contract SPE2DB25FK8LH?
SPE2DB25FK8LH was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on April 22, 2025.
How much is contract SPE2DB25FK8LH worth?
The government has obligated $1,559 on SPE2DB25FK8LH.
Is contract SPE2DB25FK8LH an order under another contract?
Yes. SPE2DB25FK8LH is a delivery order under SPE2DB22D9330, an indefinite delivery contract.
Was contract SPE2DB25FK8LH competed?
The extent of competition for SPE2DB25FK8LH was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award